Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02960230
Title H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CHE


No variant requirements are available.